Lilly Korea says KFDA approved Cymbalta, new anti-depressant.

Lilly Korea announced that the KFDA approved Cymbalta (duloxetine HCL), a new generation of anti-depressant drug, on July 30 for the treatment of major depressive disorders (MDD)

Cymbalta is an SNRI anti-depressant drug, which was approved in the U. S. and Europe in 2004 and 2005, showing an equivalent relief of depressive symptoms with SSRI anti-depressant (paroxetine) but far better imp...